BRCA2-Deficient Cancer Cells Rely on 9-1-1 Repair Complex for Survival
Memorial Sloan Kettering investigators identify critical DNA repair vulnerabilities in BRCA2-deficient tumors, immune reconstitution bottlenecks following transplant chemotherapy, and mechanisms ...






